BRD2 and Alzheimer disease: The concentration of n-3 sfPUFA was significantly lower in AD than in CH-NAT and CH-PAT (Figure 3A) while the concentration of n-6 sfPUFA (Figure 3B), and sfPUFA (Figure 3C) were similar in all clinical groups.